What's breaking now, across thousands of outlets.
(MedPage Today) -- The investigational CD19-directed chimeric antigen receptor (CAR) T-cell therapy zolacabtagene autoleucel (zola-cel) showed the potential to treat people with highly active relapsing multiple sclerosis (MS) and progressive MS...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
The Isa Local Government Council in Sokoto State has introduced free medical services for residents as part of efforts to
A gardening program in Hobart is helping people with dementia reconnect with the world around them. Researchers hope the lessons from these outdoor spaces will help more people continue to live well.
Vertex is expanding beyond its cystic fibrosis franchise.
Key PointsThe biotech company has grown its annual revenue by more than 600% over the past decade.
The Ministry of Health has, on Saturday, October 24, 2026, overseen the burial of Kenya’s third confirmed Ebola patient in Lang’ata under strict infection prevention measures while ensuring Islamic…
